Condensed Consolidated Statements Of Cash Flows (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net earnings	$ 243.2	$ 286.2
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	264.4	247.0
Stock-based compensation expense	32.5	23.3
Change in estimated sales allowances	337.1	(26.1)
Deferred income tax benefit	(92.9)	(16.7)
Loss from equity method investments	43.0	7.9
Other non-cash items	107.4	47.1
Litigation settlements, net	26.3	8.7
Changes in operating assets and liabilities:
Accounts receivable	(249.0)	(107.6)
Inventories	(178.2)	(169.2)
Trade accounts payable	0.6	81.3
Income taxes	(9.5)	(42.5)
Other operating assets and liabilities, net	(77.4)	(65.4)
Net cash provided by operating activities	447.5	274.0
Cash flows from investing activities:
Capital expenditures	(153.3)	(125.7)
Change in restricted cash	0	(50.6)
Cash paid for acquisitions, net	(33.0)	(37.1)
Proceeds from sale of property, plant and equipment	5.0	0
Purchase of marketable securities	(10.5)	(9.5)
Proceeds from sale of marketable securities	7.8	5.3
Payments for product rights and other, net	(135.3)	(13.6)
Net cash used in investing activities	(319.3)	(231.2)
Cash flows from financing activities:
Payment of financing fees	(2.6)	(18.5)
Purchase of common stock	0	(500.0)
Change in short-term borrowings, net	(193.3)	113.9
Proceeds from issuance of long-term debt	240.0	1,758.3
Payment of long-term debt	(300.0)	(1,517.3)
Proceeds from exercise of stock options	29.9	38.7
Taxes paid related to net share settlement of equity awards	(22.8)	0
Other items, net	21.3	17.2
Net cash used in financing activities	(227.5)	(107.7)
Effect on cash of changes in exchange rates	1.9	(7.7)
Net decrease in cash and cash equivalents	(97.4)	(72.6)
Cash and cash equivalents — beginning of period	291.3	350.0
Cash and cash equivalents — end of period	$ 193.9	$ 277.4